Skip to main content
Premium Trial:

Request an Annual Quote

RUCDR, BioStorage Technologies Win $7.5M VA Genotyping Contract

NEW YORK (GenomeWeb News) – The BioProcessing Solutions Alliance, a partnership between RUCDR Infinite Biologics at Rutgers University and BioStorage Technologies, has received a five-year contract from the US Department of Veterans Affairs to handle samples, genotyping and analysis, and quality control for the VA's Million Veteran Program.

RUCDR Infinite Biologics said today the partners will receive $7.5 million for the first year of the contract, which they will use to genotype and analyze 100,000 DNA samples from veteran volunteers from around the country. The remaining value of the contract has not yet been determined.

The aim of the Million Veteran Program is to build an extensive database of genetic, military exposure, lifestyle, and health information to better understand how genes affect health and illness and to improve care for veterans.

The partners will use Affymetrix's Axiom Genotyping Solution to develop a custom microarray tailored to the specific genetic and disease-related targets that have been identified by the VA, RUCDR Infinite Biologics said.

The BioProcessing Solutions Alliance launched just over a year ago. RUCDR Infinite Biologics said it is the world's largest university-based biorepository, providing DNA, RNA, and cell lines with clinical data, while BioStorage Technologies provides sample management solutions.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.